Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
05/02/2002 | EP1200594A2 Protective antigen of epstein barr virus |
05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
05/02/2002 | EP1200563A1 Attenuated influenza virus useful as vaccine |
05/02/2002 | EP1200562A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
05/02/2002 | EP1200559A2 Muscle cells and their use in cardiac repair |
05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
05/02/2002 | EP1200476A1 Antitumor antibodies, proteins, and uses thereof |
05/02/2002 | EP1200469A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
05/02/2002 | EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
05/02/2002 | EP1200459A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
05/02/2002 | EP1200132A2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
05/02/2002 | EP1200126A1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
05/02/2002 | EP1200125A1 Psca: prostate stem cell antigen and uses thereof |
05/02/2002 | EP1200123A1 Diagnosis and treatment of neuroectodermal tumors |
05/02/2002 | EP1200122A2 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
05/02/2002 | EP1200121A2 Fish vaccine |
05/02/2002 | EP1200120A1 Pneumococcal vaccines |
05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
05/02/2002 | EP1200109A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
05/02/2002 | EP1200098A2 Combined preparations comprising daunorubicin derivatives and anti her2 antibodies |
05/02/2002 | EP1200074A2 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes |
05/02/2002 | EP1078018B1 Process for extracting carotenes from carotene-containing materials |
05/02/2002 | EP0879056B1 Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes |
05/02/2002 | EP0593585B1 Peptide which abrogates tnf and lps toxicity |
05/02/2002 | CA2464228A1 Vaccine immunotherapy for immune suppressed patients |
05/02/2002 | CA2457111A1 Vaccine for treating allergy |
05/02/2002 | CA2431178A1 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
05/02/2002 | CA2426887A1 Polypeptides and polynucleodides from haemophilus influenzae and their use |
05/02/2002 | CA2426779A1 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
05/02/2002 | CA2426742A1 Haemophilus influenzae basb210 polypeptides and encoding polynucleotides and uses thereof |
05/02/2002 | CA2426738A1 Streptococcal genes |
05/02/2002 | CA2426463A1 Novel aggrecanase molecules |
05/02/2002 | CA2425770A1 Using heat shock proteins to increase immune response |
05/02/2002 | CA2425303A1 Nucleic acids and proteins from streptococcus groups a & b |
05/02/2002 | CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
05/01/2002 | CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
05/01/2002 | CN1347453A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
05/01/2002 | CN1346679A Immobilized isomerous tumor vaccine and its preparing process |
05/01/2002 | CN1346678A Weak epitope dominating system and therapeutic hepatitis B vaccine prepared with it |
05/01/2002 | CN1346677A Medicine for preventing cancer and its application method |
04/30/2002 | US6380376 Purity polypeptides |
04/30/2002 | US6380374 Isolated nucleic acid; culture product |
04/30/2002 | US6380363 Antibodies to the Ob receptor |
04/30/2002 | US6380360 Polycystic kidney disease 1 gene and uses thereof |
04/30/2002 | US6380359 Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
04/30/2002 | US6380183 Treatment of diseases involving cyst formation |
04/30/2002 | US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection |
04/30/2002 | US6379951 Compounds for immunotherapy of breast cancer and methods for their use |
04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
04/30/2002 | US6379905 Fragments of prion proteins |
04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
04/30/2002 | US6379891 A polymerase chain reaction amplification method for detecting enterically transmitted non-a/non-b viral hepatitis in a biological sample |
04/30/2002 | US6379885 Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
04/30/2002 | US6379678 Culture product; antiallergens |
04/30/2002 | US6379677 Streptococcus iniae vaccine |
04/30/2002 | US6379676 Enhancing immune response in animals |
04/30/2002 | US6379675 Immunological combination compositions and methods |
04/30/2002 | US6379672 Prevention of infectious diseases with gp96-peptide complexes |
04/30/2002 | US6379671 Using a polypeptide antigen mixture |
04/30/2002 | US6379668 Therapy for autoimmune disease |
04/30/2002 | US6379663 Immunity enhancing lactic acid bacteria |
04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
04/30/2002 | CA2176929C Vaccine against mumps containing a jeryl-lynn virus strain |
04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
04/27/2002 | CA2325063A1 Method for detecting antibodies to and antigens of fungal and yeast exposures |
04/25/2002 | WO2002033417A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
04/25/2002 | WO2002033114A2 Protein-protein interactions in neurodegenerative diseases |
04/25/2002 | WO2002033113A2 Protein-protein interactions in neurodegenerative diseases |
04/25/2002 | WO2002033112A2 Protein-protein interactions in neurodegenerative diseases |
04/25/2002 | WO2002033100A2 Regulation of human adenylate cyclase, type iv |
04/25/2002 | WO2002033099A2 Human kinases |
04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
04/25/2002 | WO2002033089A2 Ixodes scapularis tissue factor pathway inhibitor |
04/25/2002 | WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family |
04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
04/25/2002 | WO2002033062A1 REGULATION OF HUMAN ACYL-CoA DEHYDROGENASE |
04/25/2002 | WO2002033058A2 Novel cysteine proteases and uses thereof |
04/25/2002 | WO2002033050A2 Methods and compositions for promoting the maturation of monocytes |
04/25/2002 | WO2002032963A1 Immunoadjuvant systems |
04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
04/25/2002 | WO2002032946A2 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
04/25/2002 | WO2002032945A2 Haemophilus influenzae basb206 gene and protein |
04/25/2002 | WO2002032944A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |